Dr. Mayssa Hachem joined Khalifa University in Abu Dhabi, UAE, as an Assistant Professor in January 2021. She graduated from INSA, Lyon, France with a PhD in Biochemistry in 2015 and a distinction award for higher education in biochemistry. After her PhD, she undertook postdoctoral work at Sorbonne University, France. During her academic career, she has supervised a number of research projects and served on various academic and professional committees. Her areas of expertise are lipid biochemistry and drug targeting. Over the last twelve years, her main research has focused on the formulation and study of cerebral uptake (in vitro, in vivo, and ex vivo) of potential drugs with docosahexaenoic acid (DHA, 22:6n-3). The work has potential in the treatment of neurodegenerative diseases including Parkinson’s and Alzheimer’s. Targeting the brain with DHA could be an encouraging approach in the improvement of precautionary and therapeutic approaches for neurodegenerative diseases.